Study shows relation between LKB1 gene and lung cancer

Lung cancer has a high mortality: Despite prevention programms each year 1.3 million people die due to malignant mutation of lung cells. It's the most common cause of cancer-related death in men, second most common in women.

Photo: Study shows relation between LKB1 gene and lung cancer

The gene LKB1 is assumed to be a powerful tumor suppressor, keeping malignant events under control. Scientists from the University of North Carolina at Chapel Hill School of Medicine and Harvard Medical School discovered, that a defective LKB1 gene is strictly related to lung cancer.

The LKB1 gene is mutated in nearly 25 percent of human lung cancers. “Defects in this gene appear to result in a much nastier form of lung cancer called squamous cell carcinoma,” said Dr. Norman Sharpless, assistant professor of medicine and genetics in the UNC School of Medicine, member of the UNC Lineberger Comprehensive Cancer Center.

The scientists study on genetically engineered mice, which have defects in the LKB1 gene and other tumor supressors. LKB1 gene-defective mice develop cancer at a faster rate and show forms that are more likely to metastasize. The study also presented the first mouse model bearing squamous cell carcinoma.
“Mice with lung cancers harboring LKB1 mutations do much worse. We still do not know what this gene does,” added Dr. Sharpless. “But this mouse model will enable us to determine how this gene is important for lung cancer and to develop therapies targeted in a way that can help human patients.”

DNA from 144 non-small cell lung cancer patients treated at the UNC was gathered by the team, comparing the data with their mouse model.
“We should be able to sort patients into groups based on exactly what genetic lesion is causing their cancer,” said Dr. Neil Hayes, assistant professor of medicine in UNC’s School of Medicine, member of UNC Lineberger. “We hope to make better treatment decisions, depending on which therapy is most likely to target that defect.”

The Study was published in the Journal Nature.

08.08.2007

Read all latest stories

Related articles

News • Medical nanoparticles

Local treatment of lung cancer

Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines…

Photo

News • Biomarker from blood test

Lung cancer: Liquid biopsy accurately predicts immunotherapy response

A simple blood test could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.

Photo

Article • Awareness, screening, therapies

Why Europe is in need of a new lung cancer strategy

During a webinar, health experts and clinicians highlighted the need for urgent changes to lung cancer services across Europe to create a more cohesive and equal approach to care.

Related products

DK Medical – Prostar

Surgical II-C-Arms

DK Medical – Prostar

DK Medical Systems Co., Ltd
Fujifilm - FDX Visionary-C and CS

Surgical Flat Panel C-arms

Fujifilm - FDX Visionary-C and CS

FUJIFILM Europe GmbH
Intermedical – Radius Single

Surgical II-C-Arms

Intermedical – Radius Single

INTERMEDICAL SRL
JVC – CCL196

Displays – Color

JVC – CCL196

JVCKENWOOD Deutschland GmbH
JVC – CL-R211

Displays – Color

JVC – CL-R211

JVCKENWOOD Deutschland GmbH
JVC - CL-S1200

Displays - Mammo

JVC - CL-S1200

JVCKENWOOD Deutschland GmbH
Subscribe to Newsletter